• Activity INFORMATION

  Overview

  In a podcast-style discussion, Mike Corvino, PharmD, and Cole Swanson, PharmD, explore the latest treatment strategies for opportunistic infections (OIs), a significant concern for patients with compromised immune systems such as those with HIV, cancer, or transplant recipients. Left untreated, OIs can lead to severe complications, including organ damage, increased morbidity, and mortality. Proper management and prevention of OIs are crucial in improving patient outcomes and quality of life. This session seeks to provide pharmacists and nurses with an in-depth review of pharmacological treatments, prophylactic approaches, and patient monitoring techniques.

  Access the original podcast here

  
  

  Handouts

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Select appropriate patient-specific treatment strategies for OIs, considering factors such as immune status, comorbidities, and potential drug interactions

  Identify current guidelines and evidence-based strategies for managing common OIs, including pharmacological treatments and preventive measures

  Define opportunistic infections (OIs) and describe their clinical presentations, causes, and pathophysiology in immunocompromised patients

  Compare and contrast the efficacy, safety profiles, and appropriate use of antimicrobial therapies, prophylactic interventions, and patient monitoring in the treatment of OIs

  Nurse

  Select appropriate patient-specific treatment strategies for OIs, considering factors such as immune status, comorbidities, and potential drug interactions

  Define opportunistic infections (OIs) and describe their clinical presentations, causes, and pathophysiology in immunocompromised patients

  Identify current guidelines and evidence-based strategies for managing common OIs, including pharmacological treatments and preventive measures

  Compare and contrast the efficacy, safety profiles, and appropriate use of antimicrobial therapies, prophylactic interventions, and patient monitoring in the treatment of OIs

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1262696

  Universal Activity Number

  Pharmacist 0798-0000-24-259-H01-P
  Nurse 0798-0000-24-259-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Coleman  Swanson, PharmD, CDCES Clinical Pharmacist - Neurology, MUSC Specialty Pharmacy Department

  Michael  Corvino, PharmD, BCPS, BCACP, CDCES Clinical Pharmacist, Fetter Health Care Network

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).